Cargando…
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Cerebrospinal fluid (CSF) has often been used as the source of choice for biomarker discovery with the goal to support the diagnosis of neurodegenerative diseases. For this study, we selected 15 CSF protein markers which were identified in previously published clinical investigations and proposed as...
Autores principales: | T. dos Santos, Marcia Cristina, Scheller, Dieter, Schulte, Claudia, Mesa, Irene R., Colman, Peter, Bujac, Sarah R., Bell, Rosie, Berteau, Caroline, Perez, Luis Tosar, Lachmann, Ingolf, Berg, Daniela, Maetzler, Walter, Nogueira da Costa, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211693/ https://www.ncbi.nlm.nih.gov/pubmed/30383831 http://dx.doi.org/10.1371/journal.pone.0206536 |
Ejemplares similares
-
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease
por: dos Santos, Marcia Cristina T., et al.
Publicado: (2018) -
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
por: Stoessel, Daniel, et al.
Publicado: (2018) -
Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
por: Maetzler, Walter, et al.
Publicado: (2012) -
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
por: Maetzler, Walter, et al.
Publicado: (2016) -
Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study
por: Unterberger, Ursula, et al.
Publicado: (2014)